BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21871820)

  • 1. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.
    Ohshimo S; Bonella F; Sommerwerck U; Teschler H; Kamler M; Jakob HG; Kohno N; Guzman J; Costabel U
    J Heart Lung Transplant; 2011 Dec; 30(12):1374-80. PubMed ID: 21871820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
    Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
    Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients.
    Haberman B; Doan ML; Smith EO; Schecter MG; Mallory GB; Elidemir O
    Pediatr Transplant; 2010 Nov; 14(7):903-8. PubMed ID: 20667031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
    Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
    Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplant Proc; 2009 Mar; 41(2):595-8. PubMed ID: 19328934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM
    Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
    Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.
    Shitrit D; Amital A; Fox B; Kramer MR
    Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
    Berastegui C; Gómez-Ollés S; Mendoza-Valderrey A; Pereira-Veiga T; Culebras M; Monforte V; Saez B; López-Meseguer M; Sintes-Permanyer H; Ruiz de Miguel V; Bravo C; Sacanell J; Ramon MA; Romero L; Deu M; Román A
    PLoS One; 2020; 15(1):e0226488. PubMed ID: 31929536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation.
    Vos R; Cordemans C; Vanaudenaerde BM; De Vleeschauwer SI; Schoonis A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2009 May; 87(10):1579-83. PubMed ID: 19461497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in 25% to 75% forced expiratory flow as an early predictor of chronic airway rejection in pediatric lung transplant recipients.
    Rosen JB; Smith EO; Schecter MG; Mallory GB; Elidemir O
    J Heart Lung Transplant; 2012 Dec; 31(12):1288-92. PubMed ID: 23102913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
    Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
    Hübner RH; Meffert S; Mundt U; Böttcher H; Freitag S; El Mokhtari NE; Pufe T; Hirt S; Fölsch UR; Bewig B
    Eur Respir J; 2005 Mar; 25(3):494-501. PubMed ID: 15738294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.